Heights Capital Management »

Candel Therapeutics shares owned by Heights Capital Management

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Heights Capital Management from 13F filings

Historical chart of Heights Capital Management investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Heights Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Heights Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.8M 775k 4.90
2024-12-31 $260k 30k 8.68

More positions owned by Heights Capital Management

Solid Power Class A Com (SLDP)
Flutter Entmt SHS (FLUT)
Ionq Inc Pipe (IONQ)
Compass Pathways Sponsored Ads (CMPS)
Sealsq Corp Ord Shs (LAES)
Fg Merger Ii Corp (FGMC)
Jackson Acquisition Co Ii Com Shs Cl A (JACS)
Drugs Made In Amer Acqutn Ord Shs (DMAA)
Pono Cap Four Unit 03/11/2031
M3brigade Acquisition V Corp Cl A (MBAV)
Drugs Made In Amer Acq Ii Usd Ord Shs (DMII)
Kochav Defense Acqui Shs Cl A (KCHV)
Bhav Acquisition Corp Unit 03/18/2031
Xflh Cap Corp Unit 99/99/9999
Iron Horse Acquisit Ii Corp

View all positions for Heights Capital Management

Top funds holding Candel Therapeutics

FMR
Rtw Investments
Acorn Capital Advisors
BlackRock
Saturn V Capital Management
Portolan Capital Management
Vanguard Capital Management
Vanguard Group
Vestal Point Capital
Millennium Management
Geode Capital Management
Halter Ferguson Financial
State Street Corporation
Heights Capital Management
Susquehanna International

View all funds holding Candel Therapeutics